Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Erin Sizemore
Centers for Disease Control and Prevention (U.S.
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
55
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Final 18-month Outcomes of a Trial of Four-Month Rifapentine Regimens With or Without Moxifloxacin for Tuberculosis
Number of pages: 18
Posted: 20 Feb 2026
Patrick PJ Phillips
,
Ekaterina V. Kurbatova
,
Susan E. Dorman
,
Anne E. Purfield
,
Nicole E. Brown
,
Deron C. Burton
,
Angela M. Starks
,
Melinda Dunn
,
Scott Burns
,
James E. Posey
,
Lauren Cowan
,
Katherine Burri Klein
,
Mathew Ezewudo
,
Kelly E. Dooley
,
Radojka M. Savic
,
Joseph Akol
,
Carole Wallis
,
Nguyet Le
,
Alexandra Apollon
,
Claire Sadowski
,
Nigel A. Scott
, Erin Sizemore,
Kia E. Bryant
,
Wendy Carr
,
Andrew Vernon
,
Richard E. Chaisson
,
Susan Swindells
and
Payam Nahid
University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, Centers for Disease Control and Prevention (U.S., Medical University of South Carolina, Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Vanderbilt University - Medical Center, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Case Western Reserve University, Bio Analytical Research Corporation South Africa (BARC SA), National Lung Hospital, Les Centres Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Centers for Disease Control and Prevention (U.S., Johns Hopkins University, University of Nebraska Medical Center and University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis
Downloads
55
(1,010,164)
View PDF
Download
Abstract:
tuberculosis, non-inferiority, rifapentine, moxifloxacin
Feedback